Efficacy of Xuebijing Injection for Acute Pancreatitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Table 3

Meta-analyses of laboratory indicators after treatment.

Endpoints	No. studies	Pooled proportion using random-effects model		Heterogeneity
		WMD		I^2 (%)
IL-6 level	10	−18.22 (95% CI = −23.36 to −13.08)	<0.00001	97	<0.00001
TNF-α level	12	−16.44 (95% CI = −20.49 to −12.40)	<0.00001	97	<0.00001
AMS level	5	−105.61 (95% CI = −173.77 to −37.46)	0.002	95	<0.00001
WBC	6	−1.51 (95% CI = −1.66 to −1.36)	<0.00001	88	<0.00001
CRP level	5	−11.05 (95% CI = −14.32 to −7.78)	<0.00001	95	<0.00001
hs-CRP level	4	−12.39 (95% CI = −19.34 to −5.44)	0.0005	96	<0.00001

Abbreviations: WMD: weighted mean difference; CI: confidence Interval; IL-6: interleukin-6; TNF-α: tumor necrosis factor-α; AMS: serum amylase; WBC: white blood cell; CRP: C-reactive protein; hs-CRP: hypersensitive C-reactive protein.